Janet Mj Hammond
Chief Development Officer, Atea Pharmaceuticals, Inc.
Companies
- Atea Pharmaceuticals, Inc.Chief Development Officer Oct 29, 2020 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Atea Pharmaceuticals, Inc. AVIR127,665 shares2$550.2K at $4.31Jan 31, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 31, 2026Shares withheld for tax 14,136 shares at $4.24 of Atea Pharmaceuticals, Inc.2
- Jan 31, 2026Exercised options 58,050 shares of Atea Pharmaceuticals, Inc.2
- Jan 31, 2025Shares withheld for tax 14,134 shares at $3.06 of Atea Pharmaceuticals, Inc.3
- Jan 31, 2025Granted 11,250 shares of Atea Pharmaceuticals, Inc.3
- Jan 31, 2025Exercised options 46,800 shares of Atea Pharmaceuticals, Inc.3
- Feb 1, 2024Sold 14,029 shares at $3.84 of Atea Pharmaceuticals, Inc.4
- Jan 31, 2024Exercised options 46,800 shares of Atea Pharmaceuticals, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 4, 2025
- 4SEC EDGARForm 4 filed Feb 2, 2024